ArticleJACC. Case reports2026
Late Embolization of a Patent Foramen Ovale Occluder Successfully Retrieved Percutaneously.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous patent foramen ovale (PFO) closure is an established therapy for secondary prevention of cryptogenic stroke. Device embolization is a rare but potentially serious complication, usually occurring early after implantation. CASE SUMMARY: A 68-year-old woman underwent PFO closure after ischemic stroke. At 3-month follow-up, the device was not visualized on transthoracic or transesophageal echocardiography. Computed tomography angiography revealed embolization to the distal abdominal aorta. The device was successfully retrieved using a percutaneous snare technique; retrieval was complicated by an infrarenal aortic dissection that was managed conservatively. Three weeks later, the patient experienced recurrent ischemic stroke and underwent repeat PFO closure with a larger device, without further complications. DISCUSSION: Percutaneous retrieval is a feasible first-line strategy in hemodynamically stable patients. Careful anatomical assessment and appropriate device sizing are essential to reduce the risk of embolization. TAKE-HOME MESSAGES: This case highlights the importance of appropriate PFO occluder sizing in patients with PFO and atrial septum aneurysm to minimize the risk of device embolization. Although retrieval of a PFO occluder embolized into the aorta carries a risk of aortic wall injury, a percutaneous approach should be considered the first-line management strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.